Featured Article

Merk announced today that its first-in-class drug, sotatercept-csrk (Winrevair), for the treatment of pulmonary arterial hypertension (PAH) has been approved by the U.S. FDA.

Precision Oncology Today

Magazine

AI Leading the Way to More Precise Diagnostics and Disease Risk Prediction

Already a popular topic, the launch of the large language model-based chatbot, ChatGPT, at the end of 2022 increased excitement around artificial intelligence (AI)...
exposome illustration

Fully Exposed: Understanding the Exposome Can Drive the Future of Health and Wellness

The field of exposomics is still in its early stages. Pioneering researchers are grappling with methods to marry multi-omic datasets, blood and urine mass spectrometry data, and even postal code and satellite data to gain insights into the highly complex interface between human biology and environmental exposures--and how it affects human health and wellness.
Michelle Werner

In Conversation with Michelle Werner

Inside Precision Medicine’s editor in chief, Damian Doherty, spoke to Werner, Alltrna's CEO, about her career, her motivation to lead this company, and what rare disease means to her on a personal level.

Trending on Inside Precision Medicine

Brain stroke

“Brain Frailty” in Heart Patients Raises Stroke and Dementia Risk

Brain blood vessel damage that increases the risk of stroke and dementia is common in people with a range of heart conditions.
Acute lymphoblastic leukemia ALL-L2 blood smear under light microscopy

Genetic Variant Identified Responsible for Higher Risk of ALL in Latinos

Research from investigators at the Keck School of Medicine of USC has identified a key genetic variant that contributes to the increased risk of developing acute lymphoblastic leukemia among children of Hispanic/Latino origin.
Model of Antibody Bevacizumab

Cancer Drug Part of New Combination Therapy Targeting TB

Researchers have devised a host-directed therapy (HDT) approach to targeting TB, which uses the anticancer drug bevacizumab in combination with losartan, to improve blood flow within granulomas and normalize the extracellular matrix (ECM).

Daily News

Related Content

Inside Precision Medicine